 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Initial Public Offering (IPO) of Claris Lifesciences Limited will open for subscription by investors on November 24, 2010. The company is coming out with public issue of equity shares of Rs.10 each for cash aggregating to Rs.300 crores.
The 100% book building issue is priced in a price band of Rs.278 to Rs.293. The Minimum Order Quantity is 22 Equity Shares and in multiples of 22 Equity Shares. The Maximum Subscription Amount for Retail Investor is Rs.200000.
The Rating Agency Fitch Ratings India Private Limited has assigned IPO Grading of IPO Grade 3.
Enam Securities Private Limited, Edelweiss Capital Limited, JM Financial Consultants Private Limited and ICICI Securities Limited are the Book Running Lead Managers to the IPO. Edelweiss Securities Limited and JM Financial Services Private Limited are the Syndicate Members to the IPO.
Link Intime India Private Limited is the registrar to the company.
The IPO closes for subscription on November 26, 2010.